Home › Free Stock Grades › CERS
Cerus Corporation (CERS) Stock Grade
CERS · Healthcare
A+
Market Cap
$392.6M
P/E Ratio
—
Revenue Growth (YoY)
+14.4%
Net Margin
-7.6%
Return on Equity
—
Dividend Yield
None
About Cerus Corporation's fundamentals
Cerus Corporation is a medical device company with a market capitalization of $392.6 million that has demonstrated solid revenue growth of 14.4% year-over-year. Despite this growth, the company currently operates at a loss with a net margin of -7.6% and reported a net loss in its latest annual statement. However, the company generates positive free cash flow despite its accounting losses, suggesting its underlying operations produce cash even as it remains unprofitable on a net income basis.